• HOME
  • EVENTS
  • MEMBERSHIP
  • LINKS
  • OFFICERS

ASA Home

NEW JERSEY CHAPTER

  •  
  • Newsletters

  • 2013
  •   Spring
  • 2008
  • Archives

    • 2001 - 2005
    • 2006 - 2011
    • 2012 - 2015
    • 2016 - 2019
  •  

past events



  • 2021-
    • ASA NJ Chapter and Biopharmaceutical Section joint Webinar
      • On the role of hypothetical estimand strategies in our clinical trials
      • Hypothetical Strategies: Current Challenges
    • Annual ASA NJ Chapter/Bayer Statistics Workshop
      • Keynote Presentation by Prof. Andrew Gelman (Columbia University)
      • An application of the Bayesian robust meta-analytic approach in the group sequential design MDD pediatric trial, a case study
      • Bayesian design and analysis for dose ranging studies
      • Bayesian Methods in Drug Development
  • 2020-
    • ASA NJ Chapter Sponsored Webinar
      • Statistical Considerations for Development of Novel Combination Designs for Immuno-Oncology Development
      • Statistical Challenges in Designing Combination-Therapy Trials in Oncology
      • Examining horseshoe prior and knockoffs for variable selection problems in drug development
      • An adaptive-flavored group sequential design with connection to conditional error
      • Statistical Concerns for the Analysis of Data Collected by Wearable Digital Health Technology in Clinical Trials
      • Monitor On-Going Clinical Trials with a Dynamic Procedure
      • Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis
      • Statistical Considerations in the Design of COVID-19 Vaccine Trials Using Real-World Data and Evidence